Credit Suisse Ag Repare Therapeutics Inc. Transaction History

Credit Suisse Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$8.16 - $13.01 $7,760 - $12,372	-951 Reduced 3.41%	26,970 $325,000
Q2 2023 Aug 11, 2023	BUY	$8.63 - $12.53 $49,173 - $71,395	5,698 Added 25.64%	27,921 $295,000
Q1 2023 May 10, 2023	BUY	$9.32 - $15.06 $8,667 - $14,005	930 Added 4.37%	22,223 $218,000
Q4 2022 Feb 13, 2023	BUY	$12.5 - $18.13 $85,912 - $124,607	6,873 Added 47.66%	21,293 $313,000
Q3 2022 Nov 10, 2022	BUY	$11.57 - $15.59 $92 - $124	8 Added 0.06%	14,420 $176,000
Q2 2022 Aug 12, 2022	BUY	$8.45 - $14.84 $18,615 - $32,692	2,203 Added 18.04%	14,412 $202,000
Q1 2022 May 16, 2022	BUY	$11.38 - $21.88 $138,938 - $267,132	12,209 New	12,209 $175,000
Q3 2021 Nov 12, 2021	SELL	$25.71 - $35.24 $165,932 - $227,438	-6,454 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$30.1 - $34.85 $62,066 - $71,860	-2,062 Reduced 24.21%	6,454 $201,000
Q1 2021 May 14, 2021	BUY	$25.89 - $44.46 $220,479 - $378,621	8,516 New	8,516 $261,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.